For Individuals With Bipolar 1 Disorder Finding the Right Treatment Can Be a Long and Difficult Process
Originally published on LinkedIn
Our recent survey conducted with Harris Poll and Depression and Bipolar Support Alliance found that many individuals with Bipolar 1 disorder felt that finding the right treatment can be a long and difficult process.
About Alkermes
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
